0001562180-21-000339.txt : 20210113
0001562180-21-000339.hdr.sgml : 20210113
20210113170130
ACCESSION NUMBER: 0001562180-21-000339
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210111
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEKKERS MARIJN E
CENTRAL INDEX KEY: 0001216068
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38319
FILM NUMBER: 21526711
MAIL ADDRESS:
STREET 1: GENERAL ELECTRIC COMPANY
STREET 2: 41 FARNSWORTH STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quanterix Corp
CENTRAL INDEX KEY: 0001503274
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 208957988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 MIDDLESEX TURNPIKE
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 617-301-9400
MAIL ADDRESS:
STREET 1: 900 MIDDLESEX TURNPIKE
CITY: BILLERICA
STATE: MA
ZIP: 01821
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-01-11
false
0001503274
Quanterix Corp
QTRX
0001216068
DEKKERS MARIJN E
C/O QUANTERIX CORPORATION,
900 MIDDLESEX TURNPIKE
BILLERICA
MA
01821
true
false
false
false
Common Stock
2021-01-11
4
M
false
7900.00
18.24
A
16980.00
D
Common Stock
2021-01-11
4
M
false
7900.00
14.80
A
24880.00
D
Common Stock
2021-01-11
4
M
false
29162.00
8.16
A
54042.00
D
Common Stock
2021-01-11
4
S
false
7200.00
47.1656
D
46842.00
D
Common Stock
2021-01-11
4
S
false
22830.00
47.8651
D
24012.00
D
Common Stock
2021-01-11
4
S
false
2333.00
49.1564
D
21679.00
D
Common Stock
2021-01-11
4
S
false
4400.00
50.3767
D
17279.00
D
Common Stock
2021-01-11
4
S
false
8199.00
51.0821
D
9080.00
D
Stock Option (Right to Buy)
18.24
2021-01-11
4
M
false
7900.00
0.00
D
2019-12-31
2029-01-02
Common Stock
7900.00
0.00
D
Stock Option (Right to Buy)
14.80
2021-01-11
4
M
false
7900.00
0.00
D
2018-12-31
2028-08-07
Common Stock
7900.00
0.00
D
Stock Option (right to buy)
8.16
2021-01-11
4
M
false
29162.00
0.00
D
2027-03-31
Common Stock
29162.00
1951.00
D
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020.
This transaction was executed in multiple trades at prices ranging from $46.47 to $47.46. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $47.47 to $48.43. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $48.74 to $49.70. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $49.79 to $50.78. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $50.79 to $51.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 2,270 restricted stock units.
The option vests as to 25% of the shares on March 13, 2018 and vests as to an additional 2.083% of the shares per month thereafter until February 28, 2021.
/s/ Brian Keane, as Attorney-in-Fact
2021-01-13